{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:01:31Z","timestamp":1793995291555,"version":"4.8.0"},"reference-count":277,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07346-w","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:03:50Z","timestamp":1764173030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Macrophage-centred crosstalk with infiltrating immune cells in rheumatoid arthritis and its regulation by mesenchymal stem cells"],"prefix":"10.1186","volume":"23","author":[{"given":"Songyun","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"7346_CR1","first-page":"591","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD, Alpizar-Rodriguez D, Lauper K. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022;18:591\u2013602.","journal-title":"Nat Rev Rheumatol"},{"key":"7346_CR2","first-page":"300","volume":"13","author":"X Zeng","year":"2013","unstructured":"Zeng X, Zhu S, Tan A, Xie X. Disease burden and quality of life of rheumatoid arthritis in China: a systematic review. Chin J Evidence-Based Med. 2013;13:300\u201307.","journal-title":"Chin J Evidence-Based Med"},{"key":"7346_CR3","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, Ib M, Solomon DH, Strand V, Yamamoto K. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001.","journal-title":"Nat Rev Dis Primers"},{"key":"7346_CR4","doi-asserted-by":"crossref","unstructured":"McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389:2328\u201337.","DOI":"10.1016\/S0140-6736(17)31472-1"},{"key":"7346_CR5","doi-asserted-by":"crossref","unstructured":"Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford). 2012;51 Suppl 5:v3\u201311.","DOI":"10.1093\/rheumatology\/kes113"},{"key":"7346_CR6","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham C3, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010 rheumatoid arthritis classification criteria: an American college of Rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis Year. 2010;69:1580\u201388.","journal-title":"Ann Rheum Dis Year"},{"key":"7346_CR7","first-page":"228","volume":"35","author":"AF Mour\u00e3o","year":"2010","unstructured":"Mour\u00e3o AF, Canh\u00e3o H, Sousa E, Casc\u00e3o R, da Costa JB, de Almeida LS, Oliveira ME, Gomes MM, Queiroz MV, Fonseca JE. From a neutrophilic synovial tissue infiltrate to a challenging case of rheumatoid arthritis. Acta Reumatol Port. 2010;35:228\u201331.","journal-title":"Acta Reumatol Port"},{"key":"7346_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-065X.2008.00626.x","volume":"223","author":"M Feldmann","year":"2008","unstructured":"Feldmann M, Maini SR. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev. 2008;223:7\u201319.","journal-title":"Immunol Rev"},{"key":"7346_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/ard.2006.061507","volume":"66","author":"H Wittkowski","year":"2007","unstructured":"Wittkowski H, Foell D, af Klint E, De Rycke L, De Keyser F, Frosch M, Ulfgren AK, Roth J. Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis. Ann Rheum Dis Year. 2007;66:1020\u201325.","journal-title":"Ann Rheum Dis Year"},{"key":"7346_CR10","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.4049\/jimmunol.167.3.1601","volume":"167","author":"BT Wipke","year":"2001","unstructured":"Wipke BT, Allen PM. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol. 2001;167:1601\u201308.","journal-title":"The J Immunol"},{"key":"7346_CR11","doi-asserted-by":"crossref","unstructured":"Meta-analysis: diagnostic accuracy of anti\u2013cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146:797\u2013808.","DOI":"10.7326\/0003-4819-146-11-200706050-00008"},{"key":"7346_CR12","doi-asserted-by":"publisher","first-page":"k1036","DOI":"10.1136\/bmj.k1036","volume":"361","author":"BR England","year":"2018","unstructured":"England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018;361:k1036.","journal-title":"BMJ"},{"key":"7346_CR13","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1111\/1756-185X.13028","volume":"21","author":"H Hu","year":"2018","unstructured":"Hu H, Luan L, Yang K, Li SC. Burden of rheumatoid arthritis from a societal perspective: a prevalence-based study on cost of this illness for patients in China. Int J Rheum Dis. 2018;21:1572\u201380.","journal-title":"Int J Rheum Dis"},{"key":"7346_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jconrel.2022.04.001","volume":"345","author":"W Zhang","year":"2022","unstructured":"Zhang W, Chen Y, Liu Q, Zhou M, Wang K, Wang Y, Nie J, Gui S, Peng D, He Z, Li Z. Emerging nanotherapeutics alleviating rheumatoid arthritis by readjusting the seeds and soils. J Control Release. 2022;345:851\u201379.","journal-title":"J Control Release"},{"key":"7346_CR15","doi-asserted-by":"publisher","first-page":"113074","DOI":"10.1016\/j.biopha.2022.113074","volume":"150","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Hua Z, Luo X, Li Y, Yu L, Li M, Lu C, Zhao T, Liu Y. Application and pharmacological mechanism of methotrexate in rheumatoid arthritis. Biomed Pharmacother. 2022;150:113074.","journal-title":"Biomed Pharmacother"},{"key":"7346_CR16","doi-asserted-by":"crossref","unstructured":"Dhillon S. Tofacitinib: a review in rheumatoid arthritis. Drugs. 2017;77:1987\u20132001.","DOI":"10.1007\/s40265-017-0835-9"},{"key":"7346_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2217\/imt-2017-0155","volume":"10","author":"S Zhao","year":"2018","unstructured":"Zhao S, Mysler E, Moots RJ. Etanercept for the treatment of rheumatoid arthritis. Immunotherapy. 2018;10:433\u201345.","journal-title":"Immunotherapy"},{"key":"7346_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/1574887113666180314102651","volume":"13","author":"P Ruscitti","year":"2018","unstructured":"Ruscitti P, Cipriani P, Liakouli V, Carubbi F, Berardicurti O, Di Benedetto P, Ciccia F, Guggino G, Alvaro S, Triolo G, Giacomelli R. The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes. Rev Recent Clin Trials. 2018;13:210\u201314.","journal-title":"Rev Recent Clin Trials"},{"key":"7346_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3899\/jrheum.160287","volume":"44","author":"G Jones","year":"2017","unstructured":"Jones G, Wallace T, Mj M, Brockwell L, Gomez-Reino JJ, Sebba A. Five-year efficacy and safety of tocilizumab monotherapy in patients with rheumatoid arthritis who were methotrexate- and biologic-naive or free of methotrexate for 6 months: the ambition study. J Rheumatol. 2017;44:142\u201346.","journal-title":"J Rheumatol"},{"key":"7346_CR20","doi-asserted-by":"crossref","unstructured":"Blair HA, Deeks ED. Abatacept: a review in rheumatoid arthritis. Drugs. 2017;77:1221\u201333.","DOI":"10.1007\/s40265-017-0775-4"},{"key":"7346_CR21","doi-asserted-by":"crossref","unstructured":"Crotti C, Raimondo MG, Becciolini A, Biggioggero M, Favalli EG. Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date. Drug Des Devel Ther. 2017;11:211\u201323.","DOI":"10.2147\/DDDT.S104233"},{"key":"7346_CR22","doi-asserted-by":"crossref","unstructured":"Chiu YG, Ritchlin CT. Denosumab: targeting the rankl pathway to treat rheumatoid arthritis. Expert Opin Biol Ther. 2017;17:119\u201328.","DOI":"10.1080\/14712598.2017.1263614"},{"key":"7346_CR23","doi-asserted-by":"crossref","unstructured":"Friedman B, Cronstein B. Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine. 2019;86:301\u201307.","DOI":"10.1016\/j.jbspin.2018.07.004"},{"key":"7346_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/bmj.332.7534.152","volume":"332","author":"P Emery","year":"2006","unstructured":"Emery P. Treatment of rheumatoid arthritis. BMJ. 2006;332:152\u201355.","journal-title":"BMJ"},{"key":"7346_CR25","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/rheumatology\/keu039","volume":"53","author":"A Wailoo","year":"2014","unstructured":"Wailoo A, Alava MH, Scott IC, Ibrahim F, Scott DL. Cost-effectiveness of treatment strategies using combination disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis. Rheumatol (oxford). 2014;53:1773\u201377.","journal-title":"Rheumatol (oxford)"},{"key":"7346_CR26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1517\/14712598.2014.900536","volume":"14","author":"H Timlin","year":"2014","unstructured":"Timlin H. Bingham 3rd co: efficacy and safety implications of molecular constructs of biological agents for rheumatoid arthritis. Expert Opin Biol Ther. 2014;14:893\u2013904.","journal-title":"Expert Opin Biol Ther"},{"key":"7346_CR27","doi-asserted-by":"crossref","unstructured":"Smith MD. The normal synovium. Open Rheumatol J Year. 2011;5.","DOI":"10.2174\/1874312901105010100"},{"key":"7346_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","volume":"13","author":"M Bombardieri","year":"2017","unstructured":"Bombardieri M, Lewis M, Pitzalis C. Ectopic lymphoid neogenesis in rheumatic autoimmune diseases. Nat Rev Rheumatol. 2017;13:141\u201354.","journal-title":"Nat Rev Rheumatol"},{"key":"7346_CR29","doi-asserted-by":"crossref","unstructured":"Singh JA, Arayssi T, Duray P, Schumacher HR. Immunohistochemistry of normal human knee synovium: a quantitative study. Ann Rheum Dis. 2004;63:785\u201390.","DOI":"10.1136\/ard.2003.013383"},{"key":"7346_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/d41586-019-02340-x","volume":"572","author":"CD Buckley","year":"2019","unstructured":"Buckley CD. Macrophages form a protective cellular barrier in joints. Nature. 2019;572:590\u201392.","journal-title":"Nature"},{"key":"7346_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/ard.62.4.303","volume":"62","author":"MD Smith","year":"2003","unstructured":"Smith MD, Barg E, Weedon H, Papengelis V, Smeets T, Tak PP, Kraan M, Coleman M, Ahern MJ. Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. Ann Rheum Dis Year. 2003;62:303\u201307.","journal-title":"Ann Rheum Dis Year"},{"key":"7346_CR32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1172\/JCI200522263","volume":"115","author":"DK Rhee","year":"2005","unstructured":"Rhee DK, Marcelino J, Baker M, Gong Y, Smits P, Lefebvre V, Jay GD, Stewart M, Wang H, Warman ML, Carpten JD. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J. Clin. Invest. 2005;115:622\u201331.","journal-title":"J. Clin. Invest"},{"key":"7346_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7:429\u201342.","journal-title":"Nat Rev Immunol"},{"key":"7346_CR34","first-page":"579","volume":"24","author":"A Hyc","year":"2009","unstructured":"Hyc A, Osiecka-Iwan A, Niderla-Bielinska J, Jankowska-Steifer E, Moskalewski S. Pro- and anti-inflammatory cytokines increase hyaluronan production by rat synovial membrane in vitro. Int J Mol Med. 2009;24:579\u201385.","journal-title":"Int J Mol Med"},{"key":"7346_CR35","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/ard.2004.022434","volume":"64","author":"I Tchetverikov","year":"2005","unstructured":"Tchetverikov I, Lohmander LS, Verzijl N, Huizinga TW, Jm T, Hanemaaijer R, J D. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann Rheum Dis Year. 2005;64:694\u201398.","journal-title":"Ann Rheum Dis Year"},{"key":"7346_CR36","doi-asserted-by":"crossref","unstructured":"Firestein GS, Ib M. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46:183\u201396.","DOI":"10.1016\/j.immuni.2017.02.006"},{"key":"7346_CR37","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1172\/JCI117753","volume":"95","author":"B M\u00e5nsson","year":"1995","unstructured":"M\u00e5nsson B, Carey D, Alini M, Ionescu M, Rosenberg L, Poole AR, Heineg\u00e5rd D, Saxne T. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J. Clin. Invest. 1995;95:1071\u201377.","journal-title":"J. Clin. Invest"},{"key":"7346_CR38","doi-asserted-by":"crossref","unstructured":"Ng CT, Biniecka M, Kennedy A, McCormick J, Fitzgerald O, Bresnihan B, Buggy D, Taylor CT, O\u2019Sullivan J, Fearon U, Veale DJ. Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis. 2010;69:1389\u201395.","DOI":"10.1136\/ard.2009.119776"},{"key":"7346_CR39","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10787-022-00974-4","volume":"30","author":"EM Sabi","year":"2022","unstructured":"Sabi EM, Singh A, Althafar ZM, Behl T, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Alqahtani HM, Bungau S. Elucidating the role of hypoxia-inducible factor in rheumatoid arthritis. Inflammopharmacology. 2022;30:737\u201348.","journal-title":"Inflammopharmacology"},{"key":"7346_CR40","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1084\/jem.20071397","volume":"204","author":"K Hirota","year":"2007","unstructured":"Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, Yamaguchi T, Nomura T, Ito H, Nakamura T, et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med. 2007;204:2803\u201312.","journal-title":"J Exp Med"},{"key":"7346_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1172\/JCI11092","volume":"107","author":"JA Burger","year":"2001","unstructured":"Burger JA, Zvaifler NJ, Tsukada N, Firestein GS, Kipps TJ. Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism. J. Clin. Invest. 2001;107:305\u201315.","journal-title":"J. Clin. Invest"},{"key":"7346_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.coi.2021.05.011","volume":"71","author":"E McAllister","year":"2021","unstructured":"McAllister E, Jellusova J. BAFF signaling in B cell metabolism. Curr Opin Immunol. 2021;71:69\u201374.","journal-title":"Curr Opin Immunol"},{"key":"7346_CR43","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1042\/CS20220531","volume":"137","author":"Z Strizova","year":"2023","unstructured":"Strizova Z, Benesova I, Bartolini R, Novysedlak R, Cecrdlova E, Foley LK, Striz I. M1\/M2 macrophages and their overlaps - myth or reality? Clin Sci (lond). 2023;137:1067\u201393.","journal-title":"Clin Sci (lond)"},{"key":"7346_CR44","doi-asserted-by":"publisher","first-page":"102397","DOI":"10.1016\/j.autrev.2019.102397","volume":"18","author":"S Tardito","year":"2019","unstructured":"Tardito S, Martinelli G, Soldano S, Paolino S, Pacini G, Patane M, Alessandri E, Smith V, Cutolo M. Macrophage M1\/M2 polarization and rheumatoid arthritis: a systematic review. Autoimmun Rev. 2019;18:102397.","journal-title":"Autoimmun Rev"},{"key":"7346_CR45","first-page":"911","volume":"31","author":"JY Ruan","year":"2015","unstructured":"Ruan JY, Chen BC, Zhang XL, Zhang R, Huang HJ. Progress in signaling pathways of macrophage M1\/2 polarization. Immunol J. 2015;31:911\u201317.","journal-title":"Immunol J"},{"key":"7346_CR46","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","volume":"26","author":"S Alivernini","year":"2020","unstructured":"Alivernini S, MacDonald L, Elmesmari A, Finlay S, Tolusso B, Gigante MR, Petricca L, Di Mario C, Bui L, Perniola S, et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat Med. 2020;26:1295\u2013306.","journal-title":"Nat Med"},{"key":"7346_CR47","doi-asserted-by":"crossref","unstructured":"Sun W, Ma J, Zhao H, Xiao C, Zhong H, Ling H, Xie Z, Tian Q, Chen H, Zhang T, et al. Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis. Arthritis Res Ther. 2020;22:61.","DOI":"10.1186\/s13075-020-2133-2"},{"key":"7346_CR48","doi-asserted-by":"crossref","unstructured":"Xu Y, Zhang Z, He J, Chen Z. Immune effects of macrophages in rheumatoid arthritis: a bibliometric analysis from 2000 to 2021. Front Immunol. 2022;Volume 13\u20132022.","DOI":"10.3389\/fimmu.2022.903771"},{"key":"7346_CR49","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nri3088","volume":"11","author":"T Lawrence","year":"2011","unstructured":"Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11:750\u201361.","journal-title":"Nat Rev Immunol"},{"key":"7346_CR50","doi-asserted-by":"crossref","unstructured":"Ciobanu DA, Poenariu IS, Cr\u00eengu\u0219 L-I, Vreju FA, Turcu-Stiolica A, Tica AA, Padureanu V, Dumitrascu RM, Banicioiu-Covei S, Dinescu SC, et al. JAK\/STAT pathway in pathology of rheumatoid arthritis (review). Exp Ther Med. 2020;20:3498\u2013503.","DOI":"10.3892\/etm.2020.8982"},{"key":"7346_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.imlet.2021.12.004","volume":"242","author":"J Yang","year":"2022","unstructured":"Yang J, Xiong J, Guo Y, Gu L, Wu P, Tong M, Liu C, Sun J. B7-H3 blockade decreases macrophage inflammatory response and alleviates clinical symptoms of arthritis. Immunol Lett. 2022;242:46\u201353.","journal-title":"Immunol Lett"},{"key":"7346_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/cells9010111","volume":"9","author":"K Ea","year":"2020","unstructured":"Ea K, Naser SA. The role of notch signaling in macrophages during inflammation and infection: implication in rheumatoid arthritis? Cells. 2020;9:111.","journal-title":"Cells"},{"key":"7346_CR53","first-page":"172","volume":"28","author":"J Kim","year":"2020","unstructured":"Kim J, Jung KH, Yoo J, Park JH, Yan HH, Fang Z, Lim JH, Kwon S-R, Kim MK, Park H-J, Hong S-S. PBT-6, a Novel PI3KC2\u03b3 Inhibitor In Rheumatoid Arthritis. Biomolecules Ther. 2020;28:172\u201383.","journal-title":"pbt-6, a Novel PI3KC2\u03b3 Inhibitor In Rheumatoid Arthritis. Biomolecules Ther"},{"key":"7346_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-020-02389-4","volume":"23","author":"M Qadri","year":"2021","unstructured":"Qadri M, Jay GD, Zhang LX, Schmidt TA, Totonchy J, Elsaid KA. Proteoglycan-4 is an essential regulator of synovial macrophage polarization and inflammatory macrophage joint infiltration. Arthritis Res Ther Year. 2021;23:1\u201316.","journal-title":"Arthritis Res Ther Year"},{"key":"7346_CR55","doi-asserted-by":"crossref","unstructured":"Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M, Udalova IA. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011;12:231\u201338.","DOI":"10.1038\/ni.1990"},{"key":"7346_CR56","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s11427-020-1939-1","volume":"65","author":"G Ge","year":"2022","unstructured":"Ge G, Bai J, Wang Q, Liang X, Tao H, Chen H, Wei M, Niu J, Yang H, Xu Y. Punicalagin ameliorates collagen-induced arthritis by downregulating M1 macrophage and pyroptosis via NF-\u03baB signaling pathway. Sci China Life Sci. 2022;65:588\u2013603.","journal-title":"Sci China Life Sci"},{"key":"7346_CR57","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3899\/jrheum.120866","volume":"40","author":"R Brizzolara","year":"2013","unstructured":"Brizzolara R, Montagna P, Soldano S, Cutolo M. Rapid interaction between CTLA4-Ig (abatacept) and synovial macrophages from patients with rheumatoid arthritis. J Rheumatol. 2013;40:738\u201340.","journal-title":"J Rheumatol"},{"key":"7346_CR58","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1093\/rheumatology\/keac640","volume":"62","author":"MM Hanlon","year":"2023","unstructured":"Hanlon MM, McGarry T, Marzaioli V, Amaechi S, Song Q, Nagpal S, Veale DJ, Fearon U. Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations. Rheumatol (oxford). 2023;62:2611\u201320.","journal-title":"Rheumatol (oxford)"},{"key":"7346_CR59","first-page":"417","volume":"45","author":"E-J Kang","year":"2020","unstructured":"Kang E-J, Kim HJ, Choi JH, Noh J-R, Kim J-H, Lee IB, Choi Y-K, Choi D-H, An J, Oh WK. Humulus japonicus extract ameliorates collagen-induced arthritis in mice through regulation of overall articular inflammation. Int J Mol Med. 2020;45:417\u201328.","journal-title":"Int J Mol Med"},{"key":"7346_CR60","doi-asserted-by":"publisher","first-page":"11535","DOI":"10.1074\/jbc.M607999200","volume":"283","author":"F Yoshitake","year":"2008","unstructured":"Yoshitake F, Itoh S, Narita H, Ishihara K, Ebisu S. Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-\u03baB signaling pathways. J Biol Chem. 2008;283:11535\u201340.","journal-title":"J Biol Chem"},{"key":"7346_CR61","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.semarthrit.2020.10.008","volume":"51","author":"LS Simon","year":"2021","unstructured":"Simon LS, Taylor PC, Choy EH, Sebba A, Quebe A, Knopp KL, Porreca F. The Jak\/STAT pathway: a focus on pain in rheumatoid arthritis. Semin Arthritis Rheum. 2021;51:278\u201384.","journal-title":"Semin Arthritis Rheum"},{"key":"7346_CR62","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1002\/art.39837","volume":"68","author":"W O\u2019Brien","year":"2016","unstructured":"O\u2019Brien W, Fissel BM, Maeda Y, Yan J, Ge X, Gravallese EM, Aliprantis AO, Charles JF. RANK-independent osteoclast formation and bone erosion in inflammatory arthritis. Arthritis Rheumatol. 2016;68:2889\u2013900.","journal-title":"Arthritis Rheumatol"},{"key":"7346_CR63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1517\/14728222.12.2.171","volume":"12","author":"CJ Malemud","year":"2008","unstructured":"Malemud CJ, Miller AH. Pro-inflammatory cytokine-induced SAPK\/MAPK and JAK\/STAT in rheumatoid arthritis and the new anti-depression drugs. Expert Opin Ther Targets. 2008;12:171\u201383.","journal-title":"Expert Opin Ther Targets"},{"key":"7346_CR64","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.1073\/pnas.1019536108","volume":"108","author":"M Kurowska-Stolarska","year":"2011","unstructured":"Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, Reilly J, Ierna M, Fraser AR, Stolarski B, et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A. 2011;108:11193\u201398.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7346_CR65","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1093\/rheumatology\/kew272","volume":"55","author":"A Elmesmari","year":"2016","unstructured":"Elmesmari A, Fraser AR, Wood C, Gilchrist D, Vaughan D, Stewart L, McSharry C, McInnes IB, Kurowska-Stolarska M. MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in rheumatoid arthritis. Rheumatol (oxford). 2016;55:2056\u201365.","journal-title":"Rheumatol (oxford)"},{"key":"7346_CR66","doi-asserted-by":"publisher","first-page":"eaau8587","DOI":"10.1126\/scitranslmed.aau8587","volume":"11","author":"D Kuo","year":"2019","unstructured":"Kuo D, Ding J, Cohn IS, Zhang F, Wei K, Rao DA, Rozo C, Sokhi UK, Shanaj S, Oliver DJ, et al. HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness. Sci Transl Med. 2019;11:eaau8587.","journal-title":"Sci Transl Med"},{"key":"7346_CR67","doi-asserted-by":"publisher","first-page":"eabd0515","DOI":"10.1126\/sciadv.abd0515","volume":"7","author":"QQ Huang","year":"2021","unstructured":"Huang QQ, Doyle R, Chen SY, Sheng Q, Misharin AV, Mao Q, Winter DR, Pope RM. Critical role of synovial tissue-resident macrophage niche in joint homeostasis and suppression of chronic inflammation. Sci Adv. 2021;7:eabd0515.","journal-title":"Sci Adv"},{"key":"7346_CR68","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41586-019-1471-1","volume":"572","author":"S Culemann","year":"2019","unstructured":"Culemann S, Gruneboom A, Nicolas-Avila JA, Weidner D, Lammle KF, Rothe T, Quintana JA, Kirchner P, Krljanac B, Eberhardt M, et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature. 2019;572:670\u201375.","journal-title":"Nature"},{"key":"7346_CR69","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/ard.2004.029751","volume":"64","author":"JJ Haringman","year":"2005","unstructured":"Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis Year. 2005;64:834\u201338.","journal-title":"Ann Rheum Dis Year"},{"key":"7346_CR70","doi-asserted-by":"publisher","first-page":"113056","DOI":"10.1016\/j.intimp.2024.113056","volume":"142","author":"JW Chang","year":"2024","unstructured":"Chang JW, Tang CH. The role of macrophage polarization in rheumatoid arthritis and osteoarthritis: pathogenesis and therapeutic strategies. Int Immunopharmacol. 2024;142:113056.","journal-title":"Int Immunopharmacol"},{"key":"7346_CR71","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/ncomms2260","volume":"3","author":"A Kanhere","year":"2012","unstructured":"Kanhere A, Hertweck A, Bhatia U, Gokmen MR, Perucha E, Jackson I, Lord GM, Jenner RG. T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements. Nat Commun Year. 2012;3:1268.","journal-title":"Nat Commun Year"},{"key":"7346_CR72","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature07021","volume":"454","author":"L Yang","year":"2008","unstructured":"Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature. 2008;454:350\u201352.","journal-title":"Nature"},{"key":"7346_CR73","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1365-3083.1992.tb03260.x","volume":"35","author":"AM Miltenburg","year":"1992","unstructured":"Miltenburg AM, van Laar Jm, de Kuiper R, Daha MR, Breedveld FC. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol. 1992;35:603\u201310.","journal-title":"Scand J Immunol"},{"key":"7346_CR74","doi-asserted-by":"crossref","unstructured":"Klarenbeek PL, de Hair MJ, Doorenspleet ME, van Schaik BD, Esveldt RE, van de Sande MG, Cantaert T, Gerlag DM, Baeten D, van Kampen AH, et al. Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease. Ann Rheum Dis. 2012;71:1088\u201393.","DOI":"10.1136\/annrheumdis-2011-200612"},{"key":"7346_CR75","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/art.21004","volume":"52","author":"R Van Der Voort","year":"2005","unstructured":"Van Der Voort R, Van Lieshout AWT, Toonen LWJ, Sl\u00f6etjes AW, Van Den Berg WB, Figdor CG, Radstake TRDJ, Adema GJ. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis Rheum. 2005;52:1381\u201391.","journal-title":"Arthritis Rheum"},{"key":"7346_CR76","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1172\/JCI13543","volume":"108","author":"CH Kim","year":"2001","unstructured":"Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, Butcher EC. Rules of chemokine receptor association with T cell polarization in vivo. J. Clin. Invest. 2001;108:1331\u201339.","journal-title":"J. Clin. Invest"},{"key":"7346_CR77","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1111\/j.1742-4658.2008.06580.x","volume":"275","author":"T Iwamoto","year":"2008","unstructured":"Iwamoto T, Okamoto H, Toyama Y, Momohara S. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. The FEBS J. 2008;275:4448\u201355.","journal-title":"The FEBS J"},{"key":"7346_CR78","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/ard.2007.086611","volume":"68","author":"van Lieshout Aw","year":"2009","unstructured":"van Lieshout AW, van der Voort R, Toonen LW, van Helden Sf, Figdor CG, van Riel PL, Radstake TR, Adema GJ. Regulation of CXCL16 expression and secretion by myeloid cells is not altered in rheumatoid arthritis. Ann Rheum Dis. 2009;68:1036\u201343.","journal-title":"Ann Rheum Dis"},{"key":"7346_CR79","doi-asserted-by":"publisher","first-page":"R149","DOI":"10.1186\/ar2823","volume":"11","author":"T Nanki","year":"2009","unstructured":"Nanki T, Takada K, Komano Y, Morio T, Kanegane H, Nakajima A, Lipsky PE, Miyasaka N. Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther Year. 2009;11:R149.","journal-title":"Arthritis Res Ther Year"},{"key":"7346_CR80","doi-asserted-by":"crossref","unstructured":"Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum. 2005;52:3004\u201314.","DOI":"10.1002\/art.21301"},{"key":"7346_CR81","doi-asserted-by":"crossref","unstructured":"van der Voort R, van Lieshout AW, Toonen LW, Sl\u00f6etjes AW, van den Berg WB, Figdor CG, Radstake TR, Adema GJ. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis Rheum. 2005;52:1381\u201391.","DOI":"10.1002\/art.21004"},{"key":"7346_CR82","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00296-006-0241-1","volume":"27","author":"Y Kageyama","year":"2007","unstructured":"Kageyama Y, Torikai E, Nagano A. Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis. Rheumatol Int. 2007;27:467\u201372.","journal-title":"Rheumatol Int"},{"key":"7346_CR83","doi-asserted-by":"crossref","unstructured":"Giannini D, Antonucci M, Petrelli F, Bilia S, Alunno A, Puxeddu I. One year in review 2020: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2020;38:387\u201397.","DOI":"10.55563\/clinexprheumatol\/3uj1ng"},{"key":"7346_CR84","doi-asserted-by":"publisher","first-page":"1394108","DOI":"10.3389\/fimmu.2024.1394108","volume":"15","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Wei K, Jiang P, Zhao J, Shan Y, Shi Y, Zhao F, Chang C, Li Y, Zhou M, et al. Macrophage polarization in rheumatoid arthritis: signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblasts. Front Immunol Year. 2024;15:1394108.","journal-title":"Front Immunol Year"},{"key":"7346_CR85","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","volume":"41","author":"K Yasuda","year":"2019","unstructured":"Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol. 2019;41:283\u201397.","journal-title":"Semin Immunopathol"},{"key":"7346_CR86","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1002\/eji.1830241235","volume":"24","author":"JD Wagner","year":"1994","unstructured":"Wagner Jr. DH, Stout RD, Suttles J. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur J Immunol. 1994;24:3148\u201354.","journal-title":"Eur. J. Immunol"},{"key":"7346_CR87","doi-asserted-by":"publisher","first-page":"e82580","DOI":"10.1371\/journal.pone.0082580","volume":"8","author":"PM Schlegel","year":"2013","unstructured":"Schlegel PM, Steiert I, Kotter I, Muller CA. B cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls. PLoS One Year. 2013;8:e82580.","journal-title":"PLoS One Year"},{"key":"7346_CR88","doi-asserted-by":"publisher","first-page":"7526","DOI":"10.3390\/ijms24087526","volume":"24","author":"YH Wang","year":"2023","unstructured":"Wang YH, Peng YJ, Liu FC, Lin GJ, Huang SH, Sytwu HK, Cheng CP. Interleukin 26 induces macrophage IL-9 expression in rheumatoid arthritis. Int J Mol Sci. 2023;24:7526.","journal-title":"Int J Mol Sci"},{"key":"7346_CR89","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1074\/jbc.M207577200","volume":"278","author":"S Aggarwal","year":"2003","unstructured":"Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003;278:1910\u201314.","journal-title":"J Biol Chem"},{"key":"7346_CR90","doi-asserted-by":"crossref","unstructured":"Wines BD, Yap ML, Powell MS, Tan PS, Ko KK, Orlowski E, Hogarth PM. Distinctive expression of interleukin-23 receptor subunits on human Th17 and \u03b3\u03b4 T cells. Immunol Cell Biol. 2017;95:272\u201379.","DOI":"10.1038\/icb.2016.93"},{"key":"7346_CR91","doi-asserted-by":"publisher","first-page":"385352","DOI":"10.1155\/2014\/385352","volume":"2014","author":"Y Zheng","year":"2014","unstructured":"Zheng Y, Sun L, Jiang T, Zhang D, He D, Nie H. TNF\u03b1 promotes Th17 cell differentiation through IL-6 and IL-1\u03b2 produced by monocytes in rheumatoid arthritis. J Immunol Res. 2014;2014:385352.","journal-title":"J Immunol Res"},{"key":"7346_CR92","doi-asserted-by":"crossref","unstructured":"Kuwabara T, Ishikawa F, Kondo M, Kakiuchi T. The role of IL-17 and related cytokines in inflammatory autoimmune diseases. Mediators Inflamm. 2017;2017:3908061.","DOI":"10.1155\/2017\/3908061"},{"key":"7346_CR93","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.exphem.2010.06.004","volume":"38","author":"B Liu","year":"2010","unstructured":"Liu B, Tan W, Barsoum A, Gu X, Chen K, Huang W, Ramsay A, Kolls JK, Schwarzenberger P. IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement. Exp Hematol. 2010;38:877\u201384.e871.","journal-title":"Exp Hematol"},{"key":"7346_CR94","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20092301","volume":"207","author":"M Hashimoto","year":"2010","unstructured":"Hashimoto M, Hirota K, Yoshitomi H, Maeda S, Teradaira S, Akizuki S, Prieto-Martin P, Nomura T, Sakaguchi N, Kohl J, et al. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J Exp Med. 2010;207:1135\u201343.","journal-title":"J Exp Med"},{"key":"7346_CR95","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.4049\/jimmunol.2101025","volume":"208","author":"DE Muench","year":"2022","unstructured":"Muench DE, Sun Z, Sharma A, Tang C, Crampton JS, Lao C, Kersjes K, Chang W, Na S. A pathogenic Th17\/CD38+ macrophage feedback loop drives inflammatory arthritis through TNF-\u03b1. The J Immunol. 2022;208:1315\u201328.","journal-title":"The J Immunol"},{"key":"7346_CR96","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1073\/pnas.0808144106","volume":"106","author":"HG Evans","year":"2009","unstructured":"Evans HG, Gullick NJ, Kelly S, Pitzalis C, Lord GM, Kirkham BW, Taams LS. In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc Natl Acad Sci U S A. 2009;106:6232\u201337.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7346_CR97","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. The J Immunol. 1995;155:1151\u201364.","journal-title":"The J Immunol"},{"key":"7346_CR98","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775\u201387.","journal-title":"Cell"},{"key":"7346_CR99","doi-asserted-by":"crossref","unstructured":"Chen X, Oppenheim JJ. Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells. Int Immunopharmacol. 2011;11:1489\u201396.","DOI":"10.1016\/j.intimp.2011.05.018"},{"key":"7346_CR100","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/08830185.2018.1465943","volume":"37","author":"K Langdon","year":"2018","unstructured":"Langdon K, Haleagrahara N. Regulatory T-cell dynamics with abatacept treatment in rheumatoid arthritis. Int Rev Immunol. 2018;37:206\u201314.","journal-title":"Int Rev Immunol"},{"key":"7346_CR101","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2249.2005.02754.x","volume":"140","author":"M M\u00f6tt\u00f6nen","year":"2005","unstructured":"M\u00f6tt\u00f6nen M, Heikkinen J, Mustonen L, Isom\u00e4ki P, Luukkainen R, Lassila O. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol. 2005;140:360\u201367.","journal-title":"Clin Exp Immunol"},{"key":"7346_CR102","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1365-3083.2005.01656.x","volume":"62","author":"MF Liu","year":"2005","unstructured":"Liu MF, Wang CR, Fung LL, Lin LH, Tsai CN. The presence of cytokine-suppressive CD4+CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis. Scand J Immunol. 2005;62:312\u201317.","journal-title":"Scand J Immunol"},{"key":"7346_CR103","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/immu.200390024","volume":"33","author":"D Cao","year":"2003","unstructured":"Cao D, Malmstr\u00f6m V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 2003;33:215\u201323.","journal-title":"Eur. J. Immunol"},{"key":"7346_CR104","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.1158\/0008-5472.CAN-04-1987","volume":"64","author":"L Zou","year":"2004","unstructured":"Zou L, Barnett B, Safah H, Larussa VF, Evdemon-Hogan M, Mottram P, Wei S, David O, Curiel TJ, Zou W. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12\/CXCR4 signals. Cancer Res Year. 2004;64:8451\u201355.","journal-title":"Cancer Res Year"},{"key":"7346_CR105","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/cells9030549","volume":"9","author":"M Massalska","year":"2020","unstructured":"Massalska M, Radzikowska A, Kuca-Warnawin E, Plebanczyk M, Prochorec-Sobieszek M, Skalska U, Kurowska W, Maldyk P, Kontny E, Gober HJ, Maslinski W. CD4+FOXP3+ T cells in rheumatoid arthritis bone marrow are partially impaired. Cells. 2020;9:549.","journal-title":"Cells"},{"key":"7346_CR106","first-page":"2956","volume":"8","author":"T Wang","year":"2016","unstructured":"Wang T, Li S, Yang Y, Zhang K, Dong S, Wang X, Liu X, Ren Y, Zhang M, Yan X, et al. T helper 17 and T helper 1 cells are increased but regulatory T cells are decreased in subchondral bone marrow microenvironment of patients with rheumatoid arthritis. Am J Transl Res. 2016;8:2956\u201368.","journal-title":"Am J Transl Res"},{"key":"7346_CR107","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4049\/jimmunol.0903314","volume":"186","author":"M Fujimoto","year":"2011","unstructured":"Fujimoto M, Nakano M, Terabe F, Kawahata H, Ohkawara T, Han Y, Ripley B, Serada S, Nishikawa T, Kimura A, et al. The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells. The J Immunol. 2011;186:32\u201340.","journal-title":"The J Immunol"},{"key":"7346_CR108","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.immuni.2013.05.018","volume":"39","author":"van Loosdregt J","year":"2013","unstructured":"van Loosdregt J, Fleskens V, Fu J, Brenkman AB, Bekker CP, Pals CE, Meerding J, Berkers CR, Barbi J, Grone A, et al. Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases treg-cell-suppressive capacity. Immunity. 2013;39:259\u201371.","journal-title":"Immunity"},{"key":"7346_CR109","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1084\/jem.20061531","volume":"204","author":"S Nadkarni","year":"2007","unstructured":"Nadkarni S, Mauri C, Ehrenstein MR. Anti\u2013TNF-\u03b1 therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-\u03b2. J Exp Med. 2007;204:33\u201339.","journal-title":"J Exp Med"},{"key":"7346_CR110","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nm.3085","volume":"19","author":"H Nie","year":"2013","unstructured":"Nie H, Zheng Y, Li R, Guo TB, He D, Fang L, Liu X, Xiao L, Chen X, Wan B, et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-\u03b1 in rheumatoid arthritis. Nat Med. 2013;19:322\u201328.","journal-title":"Nat Med"},{"key":"7346_CR111","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","volume":"179","author":"X Chen","year":"2007","unstructured":"Chen X, Baumel M, Mannel DN, Howard OM, Oppenheim JJ. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. The J Immunol. 2007;179:154\u201361.","journal-title":"The J Immunol"},{"key":"7346_CR112","doi-asserted-by":"publisher","first-page":"19446","DOI":"10.1073\/pnas.0706832104","volume":"104","author":"MM Tiemessen","year":"2007","unstructured":"Tiemessen MM, Jagger AL, Evans HG, van Herwijnen Mj, John S, Taams LS. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes\/macrophages. Proc Natl Acad Sci U S A. 2007;104:19446\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7346_CR113","doi-asserted-by":"crossref","unstructured":"Li J, Hsu HC, Yang P, Wu Q, Li H, Edgington LE, Bogyo M, Kimberly RP, Mountz JD. Treatment of arthritis by macrophage depletion and immunomodulation: testing an apoptosis-mediated therapy in a humanized death receptor mouse model. Arthritis Rheum. 2012;64:1098\u2013109.","DOI":"10.1002\/art.33423"},{"key":"7346_CR114","doi-asserted-by":"publisher","first-page":"d197","DOI":"10.2741\/A183","volume":"2","author":"RD Stout","year":"1997","unstructured":"Stout RD, Suttles J. T cell signaling of macrophage function in inflammatory disease. Front Biosci. 1997;2:d197\u2013206.","journal-title":"Front Biosci"},{"key":"7346_CR115","doi-asserted-by":"crossref","unstructured":"Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Dahlqvist SR. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum. 2010;62:383\u201391.","DOI":"10.1002\/art.27186"},{"key":"7346_CR116","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/icb.2010.70","volume":"89","author":"G Liu","year":"2011","unstructured":"Liu G, Ma H, Qiu L, Li L, Cao Y, Ma J, Zhao Y. Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice. Immunol Cell Biol. 2011;89:130\u201342.","journal-title":"Immunol Cell Biol"},{"key":"7346_CR117","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00439-005-0033-9","volume":"118","author":"S Han","year":"2005","unstructured":"Han S, Li Y, Mao Y, Xie Y. Meta-analysis of the association of CTLA-4 exon-1 +49A\/G polymorphism with rheumatoid arthritis. Hum Genet. 2005;118:123\u201332.","journal-title":"Hum Genet"},{"key":"7346_CR118","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1073\/pnas.0806855105","volume":"105","author":"F Flores-Borja","year":"2008","unstructured":"Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2008;105:19396\u2013401.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7346_CR119","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1002\/eji.201041004","volume":"41","author":"J Herrath","year":"2011","unstructured":"Herrath J, Muller M, Amoudruz P, Janson P, Michaelsson J, Larsson PT, Trollmo C, Raghavan S, Malmstrom V. The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function. Eur. J. Immunol. 2011;41:2279\u201390.","journal-title":"Eur. J. Immunol"},{"key":"7346_CR120","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1600-065X.1987.tb01171.x","volume":"99","author":"A Lanzavecchia","year":"1987","unstructured":"Lanzavecchia A. Antigen uptake and accumulation in antigen-specific B cells. Immunol Rev. 1987;99:39\u201351.","journal-title":"Immunol Rev"},{"key":"7346_CR121","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/416603a","volume":"416","author":"EA Leadbetter","year":"2002","unstructured":"Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002;416:603\u201307.","journal-title":"Nature"},{"key":"7346_CR122","doi-asserted-by":"crossref","unstructured":"Wright GP, Stauss HJ, Ehrenstein MR. Therapeutic potential of tregs to treat rheumatoid arthritis. Semin Immunol. 2011;23:195\u2013201.","DOI":"10.1016\/j.smim.2011.07.004"},{"key":"7346_CR123","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000321185","volume":"155","author":"Q Wang","year":"2011","unstructured":"Wang Q, Ma Y, Liu D, Zhang L, Wei W. The roles of B cells and their interactions with fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis. Int Arch Allergy Immunol. 2011;155:205\u201311.","journal-title":"Int Arch Allergy Immunol"},{"key":"7346_CR124","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12016-021-08890-1","volume":"63","author":"MV Sokolova","year":"2022","unstructured":"Sokolova MV, Schett G, Steffen U. Autoantibodies in rheumatoid arthritis: historical background and novel findings. Clin Rev Allergy Immunol. 2022;63:138\u201351.","journal-title":"Clin Rev Allergy Immunol"},{"key":"7346_CR125","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/ijms23020905","volume":"23","author":"S Jang","year":"2022","unstructured":"Jang S, Kwon EJ, Lee JJ. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci. 2022;23:905.","journal-title":"Int J Mol Sci"},{"key":"7346_CR126","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13075-016-0940-2","volume":"18","author":"M Brink","year":"2016","unstructured":"Brink M, Hansson M, Mathsson-Alm L, Wijayatunga P, Verheul MK, Trouw LA, Holmdahl R, R\u00f6nnelid J, Klareskog L, Rantap\u00e4\u00e4-Dahlqvist S. Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis. Arthritis Res Ther Year. 2016;18:43.","journal-title":"Arthritis Res Ther Year"},{"key":"7346_CR127","doi-asserted-by":"publisher","first-page":"184","DOI":"10.33696\/immunology.5.184","volume":"5","author":"M Jalalvand","year":"2024","unstructured":"Jalalvand M, Khanmohammadi S, Akhtari M, Farhadi E, Jamshidi A, Mahmoudi M. Macrophages in bone and synovial inflammation in rheumatoid arthritis. J Cell Immunol. 2024;5:184\u201392.","journal-title":"J Cell Immunol"},{"key":"7346_CR128","doi-asserted-by":"publisher","first-page":"867260","DOI":"10.3389\/fimmu.2022.867260","volume":"13","author":"M Cutolo","year":"2022","unstructured":"Cutolo M, Campitiello R, Gotelli E, Soldano S. The role of M1\/M2 macrophage polarization in rheumatoid arthritis synovitis. Front Immunol. 2022;13:867260.","journal-title":"Front Immunol"},{"key":"7346_CR129","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/07853899109148051","volume":"23","author":"A Ridderstad","year":"1991","unstructured":"Ridderstad A, Abedi-Valugerdi M, Moller E. Cytokines in rheumatoid arthritis. Ann Med. 1991;23:219\u201323.","journal-title":"Ann Med"},{"key":"7346_CR130","doi-asserted-by":"publisher","first-page":"853","DOI":"10.5124\/jkma.2010.53.10.853","volume":"53","author":"JM Kim","year":"2010","unstructured":"Kim JM, Kim HY. Pathogenesis of rheumatoid arthritis. J Educ Chang The Korean Med Assoc. 2010;53:853\u201361.","journal-title":"J Educ Chang The Korean Med Assoc"},{"key":"7346_CR131","unstructured":"Thorarinsdottir K. B cell subpopulations in the pathogenesis of rheumatoid arthritis. Doctoral Thesis. 2019. University of Gothenburg."},{"key":"7346_CR132","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.4049\/jimmunol.181.6.4043","volume":"181","author":"BP Harvey","year":"2008","unstructured":"Harvey BP, Quan TE, Rudenga BJ, Roman RM, Craft J, Mamula MJ. Editing antigen presentation: antigen transfer between human B lymphocytes and macrophages mediated by class a scavenger receptors. The J Immunol. 2008;181:4043\u201351.","journal-title":"The J Immunol"},{"key":"7346_CR133","doi-asserted-by":"crossref","unstructured":"Weyand CM, Seyler TM, Goronzy JJ. B cells in rheumatoid synovitis. Arthritis Res Ther. 2005;7(3):S9\u201312.","DOI":"10.1186\/ar1737"},{"key":"7346_CR134","doi-asserted-by":"publisher","first-page":"113463","DOI":"10.1016\/j.intimp.2024.113463","volume":"143","author":"Y Su","year":"2024","unstructured":"Su Y, Liu S, Long C, Zhou Z, Zhou Y, Tang J. The cross-talk between B cells and macrophages. Int Immunopharmacol. 2024;143:113463.","journal-title":"Int Immunopharmacol"},{"key":"7346_CR135","doi-asserted-by":"crossref","unstructured":"Bombardieri M, Kam NW, Brentano F, Choi K, Filer A, Kyburz D, Ib M, Gay S, Buckley C, Pitzalis C. A BAFF\/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce aid expression and ig class-switching in B cells. Ann Rheum Dis. 2011;70:1857\u201365.","DOI":"10.1136\/ard.2011.150219"},{"key":"7346_CR136","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3389\/fimmu.2019.02058","volume":"10","author":"C Burbano","year":"2019","unstructured":"Burbano C, Villar-Vesga J, Vasquez G, Munoz-Vahos C, Rojas M, Castano D. Proinflammatory differentiation of macrophages through microparticles that form immune complexes leads to T- and B-cell activation in systemic autoimmune diseases. Front Immunol. 2019;10:2058.","journal-title":"Front Immunol"},{"key":"7346_CR137","first-page":"143","volume":"56","author":"L Quartuccio","year":"2004","unstructured":"Quartuccio L, Fabris M, Ferraccioli G. B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis. Reumatismo. 2004;56:143\u201346.","journal-title":"Reumatismo"},{"key":"7346_CR138","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1182\/blood-2004-02-0701","volume":"104","author":"HS Carlsen","year":"2004","unstructured":"Carlsen HS, Baekkevold ES, Morton HC, Haraldsen G, Brandtzaeg P. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood. 2004;104:3021\u201327.","journal-title":"Blood"},{"key":"7346_CR139","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.drudis.2016.06.009","volume":"21","author":"V Reddy","year":"2016","unstructured":"Reddy V, Dahal LN, Cragg MS, Leandro M. Optimising B-cell depletion in autoimmune disease: is obinutuzumab the answer? Drug Discov Today. 2016;21:1330\u201338.","journal-title":"Drug Discov Today"},{"key":"7346_CR140","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2011-201117","volume":"72","author":"JD Isaacs","year":"2013","unstructured":"Isaacs JD, Cohen SB, Emery P, Tak PP, Wang J, Lei G, Williams S, Lal P, Read SJ. Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. Ann Rheum Dis Year. 2013;72:329\u201336.","journal-title":"Ann Rheum Dis Year"},{"key":"7346_CR141","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41392-019-0051-z","volume":"4","author":"B Zhou","year":"2019","unstructured":"Zhou B, Zhang H, Su X, Luo Y, Li X, Yu C, Xie Q, Xia X, He G, Yang L. Therapeutic effects of a novel baff blocker on arthritis. Signal Transduct Target Ther. 2019;4:19.","journal-title":"Signal Transduct Target Ther"},{"key":"7346_CR142","doi-asserted-by":"publisher","first-page":"108078","DOI":"10.1016\/j.intimp.2021.108078","volume":"99","author":"A Singh","year":"2021","unstructured":"Singh A, Behl T, Sehgal A, Singh S, Sharma N, Naved T, Bhatia S, Al-Harrasi A, Chakrabarti P, Aleya L, et al. Mechanistic insights into the role of B cells in rheumatoid arthritis. Int Immunopharmacol Year. 2021;99:108078.","journal-title":"Int Immunopharmacol Year"},{"key":"7346_CR143","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1152\/physrev.00012.2018","volume":"99","author":"PX Liew","year":"2019","unstructured":"Liew PX, Kubes P. The Neutrophil\u2019s role during health and disease. Physiol Rev. 2019;99:1223\u201348.","journal-title":"Physiol Rev"},{"key":"7346_CR144","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.autrev.2009.12.013","volume":"9","author":"R Casc\u00e3o","year":"2010","unstructured":"Casc\u00e3o R, Ros\u00e1rio HS, Souto-Carneiro MM, Fonseca JE. Neutrophils in rheumatoid arthritis: more than simple final effectors. Autoimmun Rev. 2010;9:531\u201335.","journal-title":"Autoimmun Rev"},{"key":"7346_CR145","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrrheum.2014.80","volume":"10","author":"HL Wright","year":"2014","unstructured":"Wright HL, Moots RJ, Edwards SW. The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol. 2014;10:593\u2013601.","journal-title":"Nat Rev Rheumatol"},{"key":"7346_CR146","doi-asserted-by":"publisher","first-page":"178ra140","DOI":"10.1126\/scitranslmed.3005580","volume":"5","author":"R Khandpur","year":"2013","unstructured":"Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, Friday S, Li S, Patel RM, Subramanian V, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5:178ra140.","journal-title":"Sci Transl Med"},{"key":"7346_CR147","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1002\/eji.201646542","volume":"46","author":"G Papadaki","year":"2016","unstructured":"Papadaki G, Kambas K, Choulaki C, Vlachou K, Drakos E, Bertsias G, Ritis K, Boumpas DT, Thompson PR, Verginis P, Sidiropoulos P. Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation. Eur. J. Immunol. 2016;46:2542\u201354.","journal-title":"Eur. J. Immunol"},{"key":"7346_CR148","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/cells9040915","volume":"9","author":"E Fousert","year":"2020","unstructured":"Fousert E, Toes R, Desai J. Neutrophil extracellular traps (NETs) take the central stage in driving autoimmune responses. Cells. 2020;9:915.","journal-title":"Cells"},{"key":"7346_CR149","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532\u201335.","journal-title":"Science"},{"key":"7346_CR150","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41584-020-0459-4","volume":"16","author":"J Clarke","year":"2020","unstructured":"Clarke J. NETs directly injure cartilage in RA. Nat Rev Rheumatol. 2020;16:410.","journal-title":"Nat Rev Rheumatol"},{"key":"7346_CR151","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.4049\/jimmunol.1502353","volume":"197","author":"E Aleyd","year":"2016","unstructured":"Aleyd E, Al M, Tuk CW, van der Laken CJ, van Egmond M. IgA complexes in plasma and synovial fluid of patients with rheumatoid arthritis induce neutrophil extracellular traps via Fc\u03b1RI. The J Immunol. 2016;197:4552\u201359.","journal-title":"The J Immunol"},{"key":"7346_CR152","doi-asserted-by":"crossref","unstructured":"Yu Y, Koehn CD, Yue Y, Li S, Thiele GM, Hearth-Holmes MP, Mikuls TR, O\u2019Dell JR, Klassen LW, Zhang Z, Su K. Celastrol inhibits inflammatory stimuli-induced neutrophil extracellular trap formation. Curr Mol Med. 2015;15:401\u201310.","DOI":"10.2174\/1566524015666150505160743"},{"key":"7346_CR153","doi-asserted-by":"crossref","unstructured":"Carmona-Rivera C, Carlucci PM, Moore E, Lingampalli N, Uchtenhagen H, James E, Liu Y, Bicker KL, Wahamaa H, Hoffmann V, et al. Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis. Sci Immunol. 2017;2:eaag3358.","DOI":"10.1126\/sciimmunol.aag3358"},{"key":"7346_CR154","doi-asserted-by":"crossref","unstructured":"Sun M, Rethi B, Krishnamurthy A, Joshua V, Circiumaru A, Hensvold AH, Ossipova E, Gr\u00f6nwall C, Liu Y, Engstrom M, et al. Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts. Ann Rheum Dis. 2019;78:1621\u201331.","DOI":"10.1136\/annrheumdis-2018-214967"},{"key":"7346_CR155","doi-asserted-by":"crossref","unstructured":"Too CL, Murad S, Dhaliwal JS, Larsson P, Jiang X, Ding B, Alfredsson L, Klareskog L, Padyukov L. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis. Arthritis Res Ther. 2012;14:R250.","DOI":"10.1186\/ar4093"},{"key":"7346_CR156","doi-asserted-by":"crossref","unstructured":"Chang HH, Dwivedi N, Nicholas AP, Ho IC. The W620 polymorphism in PTPN22 disrupts its interaction with peptidylarginine deiminase type 4 and enhances citrullination and NETosis. Arthritis Rheumatol. 2015;67:2323\u201334.","DOI":"10.1002\/art.39215"},{"key":"7346_CR157","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, Jakobsson PJ, Baum W, Nimmerjahn F, Szarka E, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 2012;122:1791\u2013802.","journal-title":"J. Clin. Invest"},{"key":"7346_CR158","doi-asserted-by":"crossref","unstructured":"Carmona-Rivera C, Carlucci PM, Moore E, Lingampalli N, Uchtenhagen H, James E, Liu Y, Bicker KL, Wahamaa H, Hoffmann V, et al. Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis. Science Immunology. 2017;2:eaag3358.","DOI":"10.1126\/sciimmunol.aag3358"},{"key":"7346_CR159","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3389\/fimmu.2016.00485","volume":"7","author":"E Corsiero","year":"2016","unstructured":"Corsiero E, Pratesi F, Prediletto E, Bombardieri M, Migliorini P. NETosis as source of autoantigens in rheumatoid arthritis. Front Immunol. 2016;7:485.","journal-title":"Front Immunol"},{"key":"7346_CR160","doi-asserted-by":"publisher","first-page":"e139388","DOI":"10.1172\/jci.insight.139388","volume":"5","author":"C Carmona-Rivera","year":"2020","unstructured":"Carmona-Rivera C, Carlucci PM, Goel RR, James E, Brooks SR, Rims C, Hoffmann V, Fox DA, Buckner JH, Kaplan MJ. Neutrophil extracellular traps mediate articular cartilage damage and enhance cartilage component immunogenicity in rheumatoid arthritis. JCI Insight. 2020;5:e139388.","journal-title":"JCI Insight"},{"key":"7346_CR161","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/annrheumdis-2012-202765","volume":"73","author":"F Pratesi","year":"2014","unstructured":"Pratesi F, Dioni I, Tommasi C, Alcaro MC, Paolini I, Barbetti F, Boscaro F, Panza F, Puxeddu I, Rovero P, Migliorini P. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Ann Rheum Dis year. 2014;73:1414\u201322.","journal-title":"Ann Rheum Dis year"},{"key":"7346_CR162","doi-asserted-by":"crossref","unstructured":"Sohn DH, Rhodes C, Onuma K, Zhao X, Sharpe O, Gazitt T, Shiao R, Fert-Bober J, Cheng D, Lahey LJ, et al. Local joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis. Arthritis Rheumatol. 2015;67:2877\u201387.","DOI":"10.1002\/art.39283"},{"key":"7346_CR163","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13075-016-1031-0","volume":"18","author":"L Johansson","year":"2016","unstructured":"Johansson L, Pratesi F, Brink M, L \u00c4, D\u2019Amato C, Bartaloni D, Migliorini P, Rantap\u00e4\u00e4-Dahlqvist S. Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis. Arthritis Res Ther Year. 2016;18:127.","journal-title":"Arthritis Res Ther Year"},{"key":"7346_CR164","doi-asserted-by":"publisher","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","volume":"7","author":"J Sokolove","year":"2012","unstructured":"Sokolove J, Bromberg R, Deane KD, Lahey LJ, Derber LA, Chandra PE, Edison JD, Gilliland WR, Tibshirani RJ, Norris JM, et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One. 2012;7:e35296.","journal-title":"PLoS One"},{"key":"7346_CR165","doi-asserted-by":"crossref","unstructured":"van de Sande MGH, de Hair MJH, van der Leij C, Klarenbeek PL, Bos WH, Smith MD, Maas M, de Vries N, van Schaardenburg D, Dijkmans BAC, et al. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Annals Rheumatic Diseases. 2011;70:772\u201377.","DOI":"10.1136\/ard.2010.139527"},{"key":"7346_CR166","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nrrheum.2014.115","volume":"10","author":"AI Catrina","year":"2014","unstructured":"Catrina AI, Ytterberg AJ, Reynisdottir G, Malmstr\u00f6m V, Klareskog L. Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis. Nat Rev Rheumatol. 2014;10:645\u201353.","journal-title":"Nat Rev Rheumatol"},{"key":"7346_CR167","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","volume":"14","author":"VM Holers","year":"2018","unstructured":"Holers VM, Demoruelle MK, Kuhn KA, Buckner JH, Robinson WH, Okamoto Y, Norris JM, Deane KD. Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nat Rev Rheumatol. 2018;14:542\u201357.","journal-title":"Nat Rev Rheumatol"},{"key":"7346_CR168","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.autrev.2017.09.013","volume":"17","author":"A Balbir-Gurman","year":"2018","unstructured":"Balbir-Gurman A, Guralnik L, Yigla M, Braun-Moscovici Y, Hardak E. Imaging aspects of interstitial lung disease in patients with rheumatoid arthritis: literature review. Autoimmun Rev. 2018;17:87\u201393.","journal-title":"Autoimmun Rev"},{"key":"7346_CR169","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00408-015-9828-1","volume":"194","author":"WH Park","year":"2016","unstructured":"Park WH, Kim SS, Shim SC, Song ST, Jung SS, Kim JH, Kim N, Seo JB. Visual assessment of chest computed tomography findings in anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis: is it associated with airway abnormalities? Lung. 2016;194:97\u2013105.","journal-title":"Lung"},{"key":"7346_CR170","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205\u201319.","journal-title":"N Engl J Med"},{"key":"7346_CR171","doi-asserted-by":"crossref","unstructured":"Li CJ, Chen PK, Sun LY, Pang CY. Enhancement of mitochondrial transfer by antioxidants in human mesenchymal stem cells. Oxid Med Cell Longev. 2017;2017:8510805.","DOI":"10.1155\/2017\/8510805"},{"key":"7346_CR172","doi-asserted-by":"publisher","first-page":"e2204881","DOI":"10.1002\/advs.202204881","volume":"10","author":"C Xu","year":"2023","unstructured":"Xu C, Jiang Y, Wang H, Zhang Y, Ye Y, Qin H, Gao J, Dan Q, Du L, Liu L, et al. Arthritic microenvironment actuated nanomotors for active rheumatoid arthritis therapy. Adv Sci (Weinh). 2023;10:e2204881.","journal-title":"Adv Sci (Weinh)"},{"key":"7346_CR173","doi-asserted-by":"publisher","first-page":"e003847","DOI":"10.1136\/rmdopen-2023-003847","volume":"10","author":"H Ye","year":"2024","unstructured":"Ye H, Yang Q, Guo H, Wang X, Cheng L, Han B, Hong M, Ma F, Li M, Wu X, et al. Internalisation of neutrophils extracellular traps by macrophages aggravate rheumatoid arthritis via Rab5a. RMD Open Year. 2024;10:e003847.","journal-title":"RMD Open Year"},{"key":"7346_CR174","doi-asserted-by":"publisher","first-page":"e2307379","DOI":"10.1002\/smll.202307379","volume":"20","author":"Z Tang","year":"2024","unstructured":"Tang Z, Meng S, Yang X, Xiao Y, Wang W, Liu Y, Wu K, Zhang X, Guo H, Zhu YZ, Wang X. Neutrophil-mimetic, ros responsive, and oxygen generating nanovesicles for targeted interventions of refractory rheumatoid arthritis. Small. 2024;20:e2307379.","journal-title":"Small"},{"key":"7346_CR175","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41419-018-0710-y","volume":"9","author":"JA Marwick","year":"2018","unstructured":"Marwick JA, Mills R, Kay O, Michail K, Stephen J, Rossi AG, Dransfield I, Hirani N. Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-\u03baB activation. Cell Death Dis. 2018;9:665.","journal-title":"Cell Death Dis"},{"key":"7346_CR176","doi-asserted-by":"publisher","first-page":"483","DOI":"10.34172\/apb.2024.037","volume":"14","author":"MS Hashemzadeh","year":"2024","unstructured":"Hashemzadeh MS, Ghaleh HEG, Mohammadi M, Yousefpoor Y, Rezaei E, Alishiri G. Therapeutic effects of IL-1RA, M2 cells, and their synergistic impact on a mouse model of rheumatoid arthritis. Adv Pharm Bull. 2024;14:483\u201395.","journal-title":"Adv Pharm Bull"},{"key":"7346_CR177","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","volume":"7","author":"JL Spees","year":"2016","unstructured":"Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem\/stromal cell function. STEM Cell Res Ther. 2016;7:125.","journal-title":"STEM Cell Res Ther"},{"key":"7346_CR178","doi-asserted-by":"crossref","unstructured":"Li N, Hua J. Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci. 2017;74:2345\u201360.","DOI":"10.1007\/s00018-017-2473-5"},{"key":"7346_CR179","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12015-014-9558-4","volume":"11","author":"S Pianta","year":"2015","unstructured":"Pianta S, Signoroni PB, Muradore I, Rodrigues MF, Rossi D, Silini A, Parolini O. Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets. STEM Cell Rev Rep. 2015;11:394\u2013407.","journal-title":"STEM Cell Rev Rep"},{"key":"7346_CR180","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4049\/jimmunol.0902007","volume":"185","author":"S Ghannam","year":"2010","unstructured":"Ghannam S, P\u00e8ne J, Moquet-Torcy G, Jorgensen C, Yssel H. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. The J Immunol. 2010;185:302\u201312.","journal-title":"The J Immunol"},{"key":"7346_CR181","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1182\/blood-2010-12-324038","volume":"117","author":"D Mougiakakos","year":"2011","unstructured":"Mougiakakos D, Jitschin R, Johansson CC, Okita R, Kiessling R, Le Blanc K. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood. 2011;117:4826\u201335.","journal-title":"Blood"},{"key":"7346_CR182","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/ard.2008.101881","volume":"69","author":"E Gonzalez-Rey","year":"2010","unstructured":"Gonzalez-Rey E, Gonzalez MA, Varela N, O\u2019Valle F, Hernandez-Cortes P, Rico L, B\u00fcscher D, Delgado M. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis Year. 2010;69:241\u201348.","journal-title":"Ann Rheum Dis Year"},{"key":"7346_CR183","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/term.2958","volume":"14","author":"M Pedrosa","year":"2020","unstructured":"Pedrosa M, Gomes J, Laranjeira P, Duarte C, Pedreiro S, Antunes B, Ribeiro T, Santos F, Martinho A, Fardilha M, et al. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal\/stem cells on peripheral blood T cells from rheumatoid arthritis patients. J Tissue Eng Regen Med. 2020;14:16\u201328.","journal-title":"J Tissue Eng Regen Med"},{"key":"7346_CR184","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/1566523220666200916120708","volume":"20","author":"F Tavasolian","year":"2020","unstructured":"Tavasolian F, Hosseini AZ, Soudi S, Naderi M. miRNA-146a improves immunomodulatory effects of MSC-derived exosomes in rheumatoid arthritis. Curr Gene Ther. 2020;20:297\u2013312.","journal-title":"Curr Gene Ther"},{"key":"7346_CR185","first-page":"1134","volume":"13","author":"Y Yu","year":"2019","unstructured":"Yu Y, Yoon KA, Kang TW, Jeon HJ, Sim YB, Choe SH, Baek SY, Lee S, Seo KW, Kang KS. Therapeutic effect of long-interval repeated intravenous administration of human umbilical cord blood-derived mesenchymal stem cells in DBA\/1 mice with collagen-induced arthritis. J Tissue Eng Regen Med. 2019;13:1134\u201342.","journal-title":"J Tissue Eng Regen Med"},{"key":"7346_CR186","doi-asserted-by":"publisher","first-page":"R210","DOI":"10.1186\/ar3187","volume":"12","author":"Y Liu","year":"2010","unstructured":"Liu Y, Mu R, Wang S, Long L, Liu X, Li R, Sun J, Guo J, Zhang X, Guo J, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther Year. 2010;12:R210.","journal-title":"Arthritis Res Ther Year"},{"key":"7346_CR187","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.3892\/mmr.2016.5721","volume":"14","author":"J Zeng","year":"2016","unstructured":"Zeng J, Wang F, Mao M. Co\u2011culture of fibroblast\u2011like synoviocytes with umbilical cord\u2011mesenchymal stem cells inhibits expression of pro\u2011inflammatory proteins, induces apoptosis and promotes chondrogenesis. Mol Med Rep. 2016;14:3887\u201393.","journal-title":"Mol Med Rep"},{"key":"7346_CR188","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1111\/jcmm.12849","volume":"20","author":"RJ Dang","year":"2016","unstructured":"Dang RJ, Yang YM, Zhang L, Cui DC, Hong B, Li P, Lin Q, Wang Y, Wang QY, Xiao F, et al. A20 plays a critical role in the immunoregulatory function of mesenchymal stem cells. J Cell Mol Med. 2016;20:1550\u201360.","journal-title":"J Cell Mol Med"},{"key":"7346_CR189","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.immuni.2013.08.016","volume":"39","author":"M Xia","year":"2013","unstructured":"Xia M, Liu J, Wu X, Liu S, Li G, Han C, Song L, Li Z, Wang Q, Wang J, et al. Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20. Immun Year. 2013;39:470\u201381.","journal-title":"Immun Year"},{"key":"7346_CR190","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s13287-021-02602-4","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Yang X, Li S, Zhang B, Li S, Wang X, Wang Y, Jia C, Chang Y, Wei W. sTNFRII-fc modification protects human UC-MSCs against apoptosis\/autophagy induced by TNF-\u03b1 and enhances their efficacy in alleviating inflammatory arthritis. STEM Cell Res Ther. 2021;12:535.","journal-title":"STEM Cell Res Ther"},{"key":"7346_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01912","author":"Huan Liu","year":"2020","unstructured":"Liu H, Li R, Liu T, Yang L, Yin G, Xie Q. Immunomodulatory effects of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles in rheumatoid arthritis. Front Immunol. 2020;11:1912. https:\/\/doi.org\/10.3389\/fimmu.2020.01912","journal-title":"Frontiers in immunology"},{"key":"7346_CR192","doi-asserted-by":"publisher","first-page":"E8151","DOI":"10.1073\/pnas.1614935113","volume":"113","author":"M Mittal","year":"2016","unstructured":"Mittal M, Tiruppathi C, Nepal S, Zhao YY, Grzych D, Soni D, Prockop DJ, Malik AB. TNF\u03b1-stimulated gene-6 (TSG6) activates macrophage phenotype transition to prevent inflammatory lung injury. Proc Natl Acad Sci U S A. 2016;113:E8151\u20138158.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7346_CR193","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0002-9440(10)63018-0","volume":"159","author":"T B\u00e1rdos","year":"2001","unstructured":"B\u00e1rdos T, Kamath RV, Mikecz K, Glant TT. Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-alpha-stimulated gene-6) in murine models of experimental arthritis. Am J Pathol. 2001;159:1711\u201321.","journal-title":"Am J Pathol"},{"key":"7346_CR194","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0961203317711013","volume":"27","author":"X Yang","year":"2018","unstructured":"Yang X, Yang J, Li X, Ma W, Zou H. Bone marrow-derived mesenchymal stem cells inhibit T follicular helper cell in lupus-prone mice. Lupus. 2018;27:49\u201359.","journal-title":"Lupus"},{"key":"7346_CR195","doi-asserted-by":"publisher","first-page":"e2524","DOI":"10.1038\/cddis.2016.442","volume":"7","author":"TH Shin","year":"2016","unstructured":"Shin TH, Kim HS, Kang TW, Lee BC, Lee HY, Kim YJ, et al. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis. Cell Death Dis. 2016;7:e2524. https:\/\/doi.org\/10.1038\/cddis.2016.442","journal-title":"Cell Death Dis"},{"key":"7346_CR196","doi-asserted-by":"publisher","first-page":"144336","DOI":"10.1016\/j.gene.2020.144336","volume":"732","author":"AG Shabgah","year":"2020","unstructured":"Shabgah AG, Shariati-Sarabi Z, Tavakkol-Afshari J, Ghasemi A, Ghoryani M, Mohammadi M. A significant decrease of BAFF, APRIL, and BAFF receptors following mesenchymal stem cell transplantation in patients with refractory rheumatoid arthritis. Gene. 2020;732:144336.","journal-title":"Gene"},{"key":"7346_CR197","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.7150\/thno.21072","volume":"8","author":"S Cosenza","year":"2018","unstructured":"Cosenza S, Toupet K, Maumus M, Luz-Crawford P, Blanc-Brude O, Jorgensen C, Noel D. Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis. Theranostics. 2018;8:1399\u2013410.","journal-title":"Theranostics"},{"key":"7346_CR198","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/stem.1881","volume":"33","author":"M Franquesa","year":"2015","unstructured":"Franquesa M, Mensah FK, Huizinga R, Strini T, Boon L, Lombardo E, DelaRosa O, Laman JD, Grinyo JM, Weimar W, et al. Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. STEM Cells. 2015;33:880\u201391.","journal-title":"STEM Cells"},{"key":"7346_CR199","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.exphem.2009.01.005","volume":"37","author":"S Asari","year":"2009","unstructured":"Asari S, Itakura S, Ferreri K, Liu CP, Kuroda Y, Kandeel F, Mullen Y. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol Year. 2009;37:604\u201315.","journal-title":"Exp Hematol Year"},{"key":"7346_CR200","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/j.ymthe.2020.05.022","volume":"28","author":"N Kosaric","year":"2020","unstructured":"Kosaric N, Srifa W, Bonham CA, Kiwanuka H, Chen K, Kuehlmann BA, Maan ZN, Noishiki C, Porteus MH, Longaker MT, Gurtner GC. Macrophage subpopulation dynamics shift following intravenous infusion of mesenchymal stromal cells. Mol Ther Year. 2020;28:2007\u201322.","journal-title":"Mol Ther Year"},{"key":"7346_CR201","doi-asserted-by":"publisher","first-page":"e2206253","DOI":"10.1002\/advs.202206253","volume":"10","author":"H Zhu","year":"2023","unstructured":"Zhu H, Wu X, Liu R, Zhao Y, Sun L. ECM-Inspired hydrogels with ADSCs encapsulation for rheumatoid arthritis treatment. Adv Sci (Weinh). 2023;10:e2206253.","journal-title":"Adv Sci (Weinh)"},{"key":"7346_CR202","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.4049\/jimmunol.1500332","volume":"195","author":"MG Garimella","year":"2015","unstructured":"Garimella MG, Kour S, Piprode V, Mittal M, Kumar A, Rani L, Pote ST, Mishra GC, Chattopadhyay N, Wani MR. Adipose-derived mesenchymal stem cells prevent systemic bone loss in collagen-induced arthritis. The J Immunol. 2015;195:5136\u201348.","journal-title":"The J Immunol"},{"key":"7346_CR203","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fphys.2018.00661","volume":"9","author":"MI Guillen","year":"2018","unstructured":"Guillen MI, Platas J, Mdpd C, Mirabet V, Alcaraz MJ. Paracrine anti-inflammatory effects of adipose tissue-derived mesenchymal stem cells in human monocytes. Front Physiol. 2018;9:661.","journal-title":"Front Physiol"},{"key":"7346_CR204","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.biomaterials.2012.12.014","volume":"34","author":"D Jiang","year":"2013","unstructured":"Jiang D, Qi Y, Walker NG, Sindrilaru A, Hainzl A, Wlaschek M, MacNeil S, Scharffetter-Kochanek K. The effect of adipose tissue derived MSCs delivered by a chemically defined carrier on full-thickness cutaneous wound healing. Biomaterials. 2013;34:2501\u201315.","journal-title":"Biomaterials"},{"key":"7346_CR205","doi-asserted-by":"publisher","first-page":"38308","DOI":"10.1038\/srep38308","volume":"6","author":"AB Vasandan","year":"2016","unstructured":"Vasandan AB, Jahnavi S, Shashank C, Prasad P, Kumar A, Prasanna SJ. Human mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE(2)-dependent mechanism. Sci Rep. 2016;6:38308.","journal-title":"Sci Rep"},{"key":"7346_CR206","doi-asserted-by":"crossref","unstructured":"Moravej A, Geramizadeh B, Azarpira N, Zarnani AH, Yaghobi R, Kalani M, Khosravi M, Kouhpayeh A, Karimi MH. Mesenchymal stem cells increase skin graft survival time and up-regulate PD-L1 expression in splenocytes of mice. Immunol Lett. 2017;182:39\u201349.","DOI":"10.1016\/j.imlet.2017.01.005"},{"key":"7346_CR207","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13287-019-1156-6","volume":"10","author":"L Salda\u00f1a","year":"2019","unstructured":"Salda\u00f1a L, Bensiamar F, Vall\u00e9s G, Mancebo FJ, Garc\u00eda-Rey E, Vilaboa N. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors. STEM Cell Res Ther. 2019;10:58.","journal-title":"STEM Cell Res Ther"},{"key":"7346_CR208","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/eji.200838812","volume":"39","author":"L Martinet","year":"2009","unstructured":"Martinet L, Fleury-Cappellesso S, Gadelorge M, Dietrich G, Bourin P, Fourni\u00e9 J-J, Poupot R. A regulatory cross-talk between V\u03b39V\u03b42 T lymphocytes and mesenchymal stem cells. Eur. J. Immunol. 2009;39:752\u201362.","journal-title":"Eur. J. Immunol"},{"key":"7346_CR209","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/term.2947","volume":"13","author":"F Wei","year":"2019","unstructured":"Wei F, Li Z, Crawford R, Xiao Y, Zhou Y. Immunoregulatory role of exosomes derived from differentiating mesenchymal stromal cells on inflammation and osteogenesis. J Tissue Eng Regen Med. 2019;13:1978\u201391.","journal-title":"J Tissue Eng Regen Med"},{"key":"7346_CR210","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3389\/fimmu.2018.01658","volume":"9","author":"L Yan","year":"2018","unstructured":"Yan L, Zheng D, Xu RH. Critical role of tumor necrosis Factor signaling in mesenchymal stem cell-based therapy for autoimmune and inflammatory diseases. Front Immunol Year. 2018;9:1658.","journal-title":"Front Immunol Year"},{"key":"7346_CR211","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K N\u00e9meth","year":"2009","unstructured":"N\u00e9meth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15:42\u201349.","journal-title":"Nat Med"},{"key":"7346_CR212","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1167\/iovs.17-23067","volume":"59","author":"SK Mittal","year":"2018","unstructured":"Mittal SK, Mashaghi A, Amouzegar A, Li M, Foulsham W, Sahu SK, Chauhan SK. Mesenchymal stromal cells inhibit neutrophil effector functions in a murine model of ocular inflammation. Invest Ophthalmol Vis Sci. 2018;59:1191\u201398.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7346_CR213","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1042\/CBI20110070","volume":"35","author":"M Maqbool","year":"2011","unstructured":"Maqbool M, Vidyadaran S, George E, Ramasamy R. Human mesenchymal stem cells protect neutrophils from serum-deprived cell death. Cell Biol Int. 2011;35:1247\u201351.","journal-title":"Cell Biol Int"},{"key":"7346_CR214","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1634\/stemcells.2007-0416","volume":"26","author":"L Raffaghello","year":"2008","unstructured":"Raffaghello L, Bianchi G, Bertolotto M, Montecucco F, Busca A, Dallegri F, Ottonello L, Pistoia V. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. STEM Cells. 2008;26:151\u201362.","journal-title":"STEM Cells"},{"key":"7346_CR215","doi-asserted-by":"publisher","first-page":"e0155161","DOI":"10.1371\/journal.pone.0155161","volume":"11","author":"H Munir","year":"2016","unstructured":"Munir H, Luu NT, Clarke LS, Nash GB, Hm M. Comparative ability of mesenchymal stromal cells from different tissues to limit neutrophil recruitment to inflamed endothelium. PLoS One Year. 2016;11:e0155161.","journal-title":"PLoS One Year"},{"key":"7346_CR216","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/icb.2012.56","volume":"91","author":"K English","year":"2013","unstructured":"English K. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol. 2013;91:19\u201326.","journal-title":"Immunol Cell Biol"},{"key":"7346_CR217","doi-asserted-by":"publisher","first-page":"284215","DOI":"10.1155\/2015\/284215","volume":"2015","author":"Y Sun","year":"2015","unstructured":"Sun Y, Deng W, Geng L, Zhang L, Liu R, Chen W, Yao G, Zhang H, Feng X, Gao X, Sun L. Mesenchymal stem cells from patients with rheumatoid arthritis display impaired function in inhibiting Th17 cells. J Immunol Res. 2015;2015:284215.","journal-title":"J Immunol Res"},{"key":"7346_CR218","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/ard.2008.106435","volume":"69","author":"E Jones","year":"2010","unstructured":"Jones E, Churchman SM, English A, Buch MH, Horner EA, Burgoyne CH, Reece R, Kinsey S, Emery P, McGonagle D, Ponchel F. Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level. Ann Rheum Dis. 2010;69:450\u201357.","journal-title":"Ann Rheum Dis"},{"key":"7346_CR219","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10067-011-1816-0","volume":"31","author":"J Liang","year":"2012","unstructured":"Liang J, Li X, Zhang H, Wang D, Feng X, Wang H, Hua B, Liu B, Sun L. Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clin Rheumatol Year. 2012;31:157\u201361.","journal-title":"Clin Rheumatol Year"},{"key":"7346_CR220","doi-asserted-by":"crossref","unstructured":"Zhou B, Yuan J, Zhou Y, Ghawji Jr. M, Deng YP, Lee J, Lee AJ, Nair U, Kang AH, Brand DD, Yoo TJ. Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis. Clin Immunol. 2011;141:328\u201337.","DOI":"10.1016\/j.clim.2011.08.014"},{"key":"7346_CR221","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13287-019-1307-9","volume":"10","author":"P Luz-Crawford","year":"2019","unstructured":"Luz-Crawford P, Hernandez J, Djouad F, Luque-Campos N, Caicedo A, Carr\u00e8re-Kremer S, Brondello JM, Vignais ML, P\u00e8ne J, Jorgensen C. Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer. STEM Cell Res Ther. 2019;10:232.","journal-title":"STEM Cell Res Ther"},{"key":"7346_CR222","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41422-020-0315-8","volume":"30","author":"J Yu","year":"2020","unstructured":"Yu J, Qin B, Moyer AM, Nowsheen S, Tu X, Dong H, Boughey JC, Goetz MP, Weinshilboum R, Lou Z, Wang L. Regulation of sister chromatid cohesion by nuclear PD-L1. Cell Res Year. 2020;30:590\u2013601.","journal-title":"Cell Res Year"},{"key":"7346_CR223","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/intimm\/dxs098","volume":"25","author":"M-L Thibult","year":"2012","unstructured":"Thibult M-L, Mamessier E, Gertner-Dardenne J, Pastor S, Just-Landi S, Xerri L, Chetaille B, Olive D. PD-1 is a novel regulator of human B-cell activation. Int Immunol Year. 2012;25:129\u201337.","journal-title":"Int Immunol Year"},{"key":"7346_CR224","doi-asserted-by":"publisher","first-page":"2204998","DOI":"10.1002\/advs.202204998","volume":"10","author":"Y Liu","year":"2023","unstructured":"Liu Y, Rao P, Qian H, Shi Y, Chen S, Lan J, Mu D, Chen R, Zhang X, Deng C, et al. Regulatory fibroblast-like synoviocytes cell membrane coated nanoparticles: a novel targeted therapy for rheumatoid arthritis. Adv Sci Year. 2023;10:2204998.","journal-title":"Adv Sci Year"},{"key":"7346_CR225","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunological Rev. 2010;233:233\u201355.","journal-title":"Immunological Rev"},{"key":"7346_CR226","doi-asserted-by":"crossref","unstructured":"Pab\u00f3n-Porras MA, Molina-R\u00edos S, Fl\u00f3rez-Su\u00e1rez JB, Coral-Alvarado PX, M\u00e9ndez-Patarroyo P, Quintana-L\u00f3pez G. Rheumatoid arthritis and systemic lupus erythematosus: pathophysiological mechanisms related to innate immune system. Sage Open Med. 2019;2019.","DOI":"10.1177\/2050312119876146"},{"key":"7346_CR227","unstructured":"Margaritopoulos GA, Antoniou KM, Lasithiotaki I, Proklou A, Soufla G, Siafakas NM. Expression of SDF-1\/CXCR4 axis in bone marrow mesenchymal stem cells derived from rheumatoid arthritis-usual interstitial pneumonia. Clin Exp Rheumatol. 2013;31:610\u201311."},{"key":"7346_CR228","doi-asserted-by":"crossref","unstructured":"Li W, Liu Q, Shi J, Xu X, Xu J. The role of TNF-\u03b1 in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment. Front Immunol. 2023;Volume 14\u20132023.","DOI":"10.3389\/fimmu.2023.1074863"},{"key":"7346_CR229","doi-asserted-by":"publisher","first-page":"3924858","DOI":"10.1155\/2016\/3924858","volume":"2016","author":"A Saparov","year":"2016","unstructured":"Saparov A, Ogay V, Nurgozhin T, Jumabay M, Chen WCW. Preconditioning of human mesenchymal stem cells to enhance their regulation of the immune response. STEM Cells Int. 2016;2016:3924858.","journal-title":"STEM Cells Int"},{"key":"7346_CR230","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/stem.3190","volume":"38","author":"V Strauch","year":"2020","unstructured":"Strauch V, Saul D, Berisha M, Mackensen A, Mougiakakos D, Jitschin R. N-glycosylation controls inflammatory licensing-triggered PD-L1 upregulation in human mesenchymal stromal cells. STEM Cells Year. 2020;38:986\u201393.","journal-title":"STEM Cells Year"},{"key":"7346_CR231","doi-asserted-by":"publisher","first-page":"e12067","DOI":"10.1002\/jev2.12067","volume":"10","author":"M Li","year":"2021","unstructured":"Li M, Soder R, Abhyankar S, Abdelhakim H, Braun MW, Trinidad CV, Pathak HB, Pessetto Z, Deighan C, Ganguly S, et al. WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1. J Extracell Vesicles. 2021;10:e12067.","journal-title":"J Extracell Vesicles"},{"key":"7346_CR232","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13287-025-04315-4","volume":"16","author":"M Rossello-Gelabert","year":"2025","unstructured":"Rossello-Gelabert M, Igartua M, Santos-Vizcaino E, Hernandez RM. Fine-tuning licensing strategies to boost MSC-based immunomodulatory secretome. STEM Cell Res Ther. 2025;16:183.","journal-title":"STEM Cell Res Ther"},{"key":"7346_CR233","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/stem.2509","volume":"35","author":"LC Davies","year":"2016","unstructured":"Davies LC, Heldring N, Kadri N, Le Blanc K. Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. STEM Cells. 2016;35:766\u201376.","journal-title":"STEM Cells"},{"key":"7346_CR234","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41419-022-04822-9","volume":"13","author":"Y He","year":"2022","unstructured":"He Y, Qu Y, Meng B, Huang W, Tang J, Wang R, Chen Z, Kou X, Shi S. Mesenchymal stem cells empower T cells in the lymph nodes via MCP-1\/PD-L1 axis. Cell Death Dis. 2022;13:365.","journal-title":"Cell Death Dis"},{"key":"7346_CR235","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","volume":"111","author":"GM Spaggiari","year":"2008","unstructured":"Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer\u2013cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood Year. 2008;111:1327\u201333.","journal-title":"Blood Year"},{"key":"7346_CR236","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13287-025-04362-x","volume":"16","author":"J Liu","year":"2025","unstructured":"Liu J, Zhang X, Zhao X, Ren J, Huang H, Zhang C, Chen X, Li W, Wei J, Li X. Activation of eIF2\u03b1-ATF4 by endoplasmic reticulum-mitochondria coupling stress enhances COX2 expression and MSC-based therapeutic efficacy for rheumatoid arthritis. STEM Cell Res Ther. 2025;16:260.","journal-title":"STEM Cell Res Ther"},{"key":"7346_CR237","doi-asserted-by":"crossref","unstructured":"He X, Yang Y, Yao M, Yang L, Ao L, Hu X, Li Z, Wu X, Tan Y, Xing W, et al. Combination of human umbilical cord mesenchymal stem (stromal) cell transplantation with IFN-\u03b3 treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis. Ann Rheum Dis. 2020;79:1298\u2013304.","DOI":"10.1136\/annrheumdis-2020-217798"},{"key":"7346_CR238","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3389\/fimmu.2018.01658","volume":"9","author":"L Yan","year":"2018","unstructured":"Yan L, Zheng D, Xu RH. Critical role of tumor necrosis Factor signaling in mesenchymal stem cell-based therapy for autoimmune and inflammatory diseases. Front Immunol Year. 2018;9:1658.","journal-title":"Front Immunol Year"},{"key":"7346_CR239","doi-asserted-by":"crossref","unstructured":"Park N, Rim YA, Jung H, Kim J, Yi H, Kim Y, Jang Y, Jung SM, Lee J, Kwok SK, et al. Etanercept-synthesising mesenchymal stem cells efficiently ameliorate collagen-induced arthritis. Sci Rep. 2017;7:39593.","DOI":"10.1038\/srep39593"},{"key":"7346_CR240","doi-asserted-by":"publisher","first-page":"121474","DOI":"10.1016\/j.biomaterials.2022.121474","volume":"283","author":"Y Lu","year":"2022","unstructured":"Lu Y, Li Z, Li L, Chen J, Xu X, Lin Z, Zhang T, Zhu Y, Ding C, Mao C. Highly effective rheumatoid arthritis therapy by peptide-promoted nanomodification of mesenchymal stem cells. Biomaterials. 2022;283:121474.","journal-title":"Biomaterials"},{"key":"7346_CR241","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/ar2939","volume":"12","author":"E Schurgers","year":"2010","unstructured":"Schurgers E, Kelchtermans H, Mitera T, Geboes L, Matthys P. Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis. Arthritis Res Ther Year. 2010;12:R31.","journal-title":"Arthritis Res Ther Year"},{"key":"7346_CR242","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107:367\u201372.","journal-title":"Blood"},{"key":"7346_CR243","first-page":"1256","volume":"35","author":"S Bosello","year":"2008","unstructured":"Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D, Morelli A, Ferraccioli G. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol. 2008;35:1256\u201364.","journal-title":"J Rheumatol"},{"key":"7346_CR244","doi-asserted-by":"publisher","first-page":"107202","DOI":"10.4252\/wjsc.v17.i7.107202","volume":"17","author":"F Sengul Bag","year":"2025","unstructured":"Sengul Bag F, Bag OF. Molecular and therapeutic effects of mesenchymal stem cell-derived exosomes on autoimmune diseases. World J STEM Cells. 2025;17:107202.","journal-title":"World J STEM Cells"},{"key":"7346_CR245","doi-asserted-by":"crossref","unstructured":"Luk F, Carreras-Planella L, Korevaar SS, de Witte Sfh, Borr\u00e0s FE, Betjes MGH, Baan CC, Hoogduijn MJ, Franquesa M. Inflammatory conditions dictate the effect of mesenchymal stem or stromal cells on B cell function. Front Immunol. 2017;8:1042.","DOI":"10.3389\/fimmu.2017.01042"},{"key":"7346_CR246","doi-asserted-by":"publisher","first-page":"957797","DOI":"10.3389\/fimmu.2022.957797","volume":"13","author":"SG Garcia","year":"2022","unstructured":"Garcia SG, Sandoval-Hell\u00edn N, Clos-Sansalvador M, Carreras-Planella L, Mor\u00f3n-Font M, Guerrero D, Borr\u00e0s FE, Franquesa M. Mesenchymal stromal cells induced regulatory B cells are enriched in extracellular matrix genes and IL-10 independent modulators. Front Immunol Year. 2022;13:957797.","journal-title":"Front Immunol Year"},{"key":"7346_CR247","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/leu.2014.225","volume":"29","author":"Y Peng","year":"2015","unstructured":"Peng Y, Chen X, Liu Q, Zhang X, Huang K, Liu L, Li H, Zhou M, Huang F, Fan Z, et al. Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. Leukemia Year. 2015;29:636\u201346.","journal-title":"Leukemia Year"},{"key":"7346_CR248","doi-asserted-by":"crossref","unstructured":"Luk F, Carreras-Planella L, Korevaar SS, de Witte Sfh, Borr\u00e0s FE, Betjes MGH, Baan CC, Hoogduijn MJ, Franquesa M. Inflammatory conditions dictate the effect of mesenchymal stem or stromal cells on B cell function. Frontiers Immunology. 2017;8\u20132017.","DOI":"10.3389\/fimmu.2017.01042"},{"key":"7346_CR249","doi-asserted-by":"publisher","first-page":"104025","DOI":"10.1016\/j.cellimm.2019.104025","volume":"347","author":"R Chen","year":"2020","unstructured":"Chen R, Cao Y, Tian Y, Gu Y, Lu H, Zhang S, Xu H, Su Z. PGE2 ameliorated viral myocarditis development and promoted IL-10-producing regulatory B cell expansion via MAPKs\/AKT-AP1 axis or AhR signaling. Cell Immunol Year. 2020;347:104025.","journal-title":"Cell Immunol Year"},{"key":"7346_CR250","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/stem.1881","volume":"33","author":"M Franquesa","year":"2015","unstructured":"Franquesa M, Mensah FK, Huizinga R, Strini T, Boon L, Lombardo E, DelaRosa O, Laman JD, Griny\u00f3 JM, Weimar W, et al. Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. STEM Cells. 2015;33:880\u201391.","journal-title":"STEM Cells"},{"key":"7346_CR251","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1002\/art.27560","volume":"62","author":"F Schena","year":"2010","unstructured":"Schena F, Gambini C, Gregorio A, Mosconi M, Reverberi D, Gattorno M, Casazza S, Uccelli A, Moretta L, Martini A, Traggiai E. Interferon-\u03b3\u2013dependent inhibition of B cell activation by bone marrow\u2013derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum. 2010;62:2776\u201386.","journal-title":"Arthritis Rheum"},{"key":"7346_CR252","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13075-018-1611-2","volume":"20","author":"E Armas-Gonz\u00e1lez","year":"2018","unstructured":"Armas-Gonz\u00e1lez E, Dom\u00ednguez-Luis MJ, D\u00edaz-Mart\u00edn A, Arce-Franco M, Castro-Hern\u00e1ndez J, Danelon G, Hern\u00e1ndez-Hern\u00e1ndez V, Bustabad-Reyes S, Cantabrana A, Uguccioni M, D\u00edaz-Gonz\u00e1lez F. Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis. Arthritis Res Ther Year. 2018;20:114.","journal-title":"Arthritis Res Ther Year"},{"key":"7346_CR253","doi-asserted-by":"crossref","unstructured":"Bao YQ, Wang JP, Dai ZW, Mao YM, Wu J, Guo HS, Xia YR, Ye DQ. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis. Clin Rheumatol. 2020;39:281\u201390.","DOI":"10.1007\/s10067-019-04775-z"},{"key":"7346_CR254","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1093\/rheumatology\/keab639","volume":"61","author":"C Rempenault","year":"2022","unstructured":"Rempenault C, Mielle J, Schreiber K, Corbeau P, Macia L, Combe B, Morel J, Daien CI, Audo R. CXCR5\/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis. Rheumatol (oxford). 2022;61:2185\u201396.","journal-title":"Rheumatol (oxford)"},{"key":"7346_CR255","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jconrel.2018.12.019","volume":"294","author":"HH Wu","year":"2019","unstructured":"Wu HH, Zhou Y, Tabata Y, Gao JQ. Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic. J Control Release. 2019;294:102\u201313.","journal-title":"J Control Release"},{"key":"7346_CR256","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41419-021-04136-2","volume":"12","author":"CH Tsai","year":"2021","unstructured":"Tsai CH, Chen CJ, Gong CL, Liu SC, Chen PC, Huang CC, Hu SL, Wang SW, Tang CH. CXCL13\/CXCR5 axis facilitates endothelial progenitor cell homing and angiogenesis during rheumatoid arthritis progression. Cell Death Dis. 2021;12:846.","journal-title":"Cell Death Dis"},{"key":"7346_CR257","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3390\/ijms19072012","volume":"19","author":"IJ MacDonald","year":"2018","unstructured":"MacDonald IJ, Liu SC, Su CM, Wang YH, Tsai CH, Tang CH. Implications of angiogenesis involvement in arthritis. Int J Mol Sci. 2018;19:2012.","journal-title":"Int J Mol Sci"},{"key":"7346_CR258","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12865-015-0068-1","volume":"16","author":"E Klimatcheva","year":"2015","unstructured":"Klimatcheva E, Pandina T, Reilly C, Torno S, Bussler H, Scrivens M, Jonason A, Mallow C, Doherty M, Paris M, et al. CXCL13 antibody for the treatment of autoimmune disorders. BMC Immunol Year. 2015;16:6.","journal-title":"BMC Immunol Year"},{"key":"7346_CR259","doi-asserted-by":"publisher","first-page":"144336","DOI":"10.1016\/j.gene.2020.144336","volume":"732","author":"A Gowhari Shabgah","year":"2020","unstructured":"Gowhari Shabgah A, Shariati-Sarabi Z, Tavakkol-Afshari J, Ghasemi A, Ghoryani M, Mohammadi M. A significant decrease of BAFF, APRIL, and BAFF receptors following mesenchymal stem cell transplantation in patients with refractory rheumatoid arthritis. Gene. 2020;732:144336.","journal-title":"Gene"},{"key":"7346_CR260","doi-asserted-by":"crossref","unstructured":"Kennedy A, Fearon U, Veale DJ, Godson C. Macrophages in synovial inflammation. Front Immunol. 2011;2:52.","DOI":"10.3389\/fimmu.2011.00052"},{"key":"7346_CR261","doi-asserted-by":"crossref","unstructured":"Bozec A, Luo Y, Engdahl C, Figueiredo C, Bang H, Schett G. Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner. Arthritis Res Ther Year. 2018;20:24.","DOI":"10.1186\/s13075-018-1527-x"},{"key":"7346_CR262","doi-asserted-by":"crossref","unstructured":"Kurth TB, Dell\u2019accio F, Crouch V, Augello A, Sharpe PT, De Bari C. Functional mesenchymal stem cell niches in adult mouse knee joint synovium in vivo. Arthritis Rheum. 2011;63:1289\u2013300.","DOI":"10.1002\/art.30234"},{"key":"7346_CR263","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K N\u00e9meth","year":"2009","unstructured":"N\u00e9meth K, Leelahavanichkul A, Yuen PST, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2\u2013dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15:42\u201349.","journal-title":"Nat Med"},{"key":"7346_CR264","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.1101029","volume":"188","author":"P Kalinski","year":"2012","unstructured":"Kalinski P. Regulation of immune responses by prostaglandin E2. The J Immunol. 2012;188:21\u201328.","journal-title":"The J Immunol"},{"key":"7346_CR265","doi-asserted-by":"publisher","first-page":"e0136304","DOI":"10.1371\/journal.pone.0136304","volume":"10","author":"M Yasui","year":"2015","unstructured":"Yasui M, Tamura Y, Minami M, Higuchi S, Fujikawa R, Ikedo T, Nagata M, Arai H, Murayama T, Yokode M. The prostaglandin E2 receptor EP4 regulates obesity-related inflammation and insulin sensitivity. PLoS One Year. 2015;10:e0136304.","journal-title":"PLoS One Year"},{"key":"7346_CR266","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1002\/eji.201545471","volume":"45","author":"YR Na","year":"2015","unstructured":"Na YR, Jung D, Yoon BR, Lee WW, Seok SH. Endogenous prostaglandin E2 potentiates anti-inflammatory phenotype of macrophage through the CREB-C\/EBP-\u03b2 cascade. Eur. J. Immunol. 2015;45:2661\u201371.","journal-title":"Eur. J. Immunol"},{"key":"7346_CR267","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3390\/cells8121596","volume":"8","author":"X Yang","year":"2019","unstructured":"Yang X, Li S, Zhao Y, Li S, Zhao T, Tai Y, Zhang B, Wang X, Wang C, Chen J, et al. GRK2 mediated abnormal transduction of PGE2-EP4-cAMP-CREB signaling induces the imbalance of macrophages polarization in collagen-induced arthritis mice. Cells. 2019;8:1596.","journal-title":"Cells"},{"key":"7346_CR268","doi-asserted-by":"publisher","first-page":"112575","DOI":"10.1016\/j.yexcr.2021.112575","volume":"402","author":"Y Wei","year":"2021","unstructured":"Wei Y, Liang M, Xiong L, Su N, Gao X, Jiang Z. PD-L1 induces macrophage polarization toward the M2 phenotype via Erk\/Akt\/mTOR. Exp Cell Res. 2021;402:112575.","journal-title":"Exp Cell Res"},{"key":"7346_CR269","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2174\/1574888X17666220127110332","volume":"17","author":"C Tu","year":"2022","unstructured":"Tu C, Wang Z, Xiang E, Zhang Q, Zhang Y, Wu P, Li C, Wu D. Human umbilical cord mesenchymal stem cells promote macrophage PD-L1 expression and attenuate acute lung injury in mice. Curr STEM Cell Res Ther. 2022;17:564\u201375.","journal-title":"Curr STEM Cell Res Ther"},{"key":"7346_CR270","doi-asserted-by":"crossref","unstructured":"Bouchlaka MN, Moffitt AB, Kim J, Kink JA, Bloom DD, Love C, Dave S, Hematti P, Capitini CM. Human mesenchymal stem cell-educated Macrophages are a distinct high IL-6-Producing subset that confer protection in graft-versus-host-disease and radiation injury models. Biol Blood Marrow Transplant. 2017;23:897\u2013905.","DOI":"10.1016\/j.bbmt.2017.02.018"},{"key":"7346_CR271","doi-asserted-by":"crossref","unstructured":"Zhang B, Yin Y, Lai RC, Tan SS, Choo AB, Lim SK. Mesenchymal stem cells secrete immunologically active exosomes. STEM Cells Dev. 2014;23:1233\u201344.","DOI":"10.1089\/scd.2013.0479"},{"key":"7346_CR272","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/term.3368","volume":"16","author":"M Babaahmadi","year":"2022","unstructured":"Babaahmadi M, Tayebi B, Gholipour NM, Bendele P, Pheneger J, Kheimeh A, Kamali A, Molazem M, Baharvand H, Eslaminejad MB, et al. Long-term passages of human clonal mesenchymal stromal cells can alleviate the disease in the rat model of collagen-induced arthritis resembling early passages of different heterogeneous cells. J Tissue Eng Regen Med. 2022;16:1261\u201375.","journal-title":"J Tissue Eng Regen Med"},{"key":"7346_CR273","unstructured":"Sun Y, Kong W, Huang S, Shi B, Zhang H, Chen W, Zhang H, Zhao C, Tang X, Yao G, et al. Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment. Clin Exp Rheumatol. 2017;35:288\u201395."},{"key":"7346_CR274","doi-asserted-by":"publisher","first-page":"22293","DOI":"10.1038\/srep22293","volume":"6","author":"H Wang","year":"2016","unstructured":"Wang H, Liang X, Xu ZP, Crawford DHG, Liu X, Roberts MS. A physiologically based kinetic model for elucidating the in vivo distribution of administered mesenchymal stem cells. Sci Rep. 2016;6:22293.","journal-title":"Sci Rep"},{"key":"7346_CR275","doi-asserted-by":"crossref","unstructured":"Eggenhofer E, Benseler V, Kroemer A, Popp F, Geissler E, Schlitt H, Baan C, Dahlke M, Hoogduijn MJ. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. 2012;Volume 3\u20132012.","DOI":"10.3389\/fimmu.2012.00297"},{"key":"7346_CR276","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jcyt.2013.03.005","volume":"15","author":"L Barkholt","year":"2013","unstructured":"Barkholt L, Flory E, Jekerle V, Lucas-Samuel S, Ahnert P, Bisset L, B\u00fcscher D, Fibbe W, Foussat A, Kwa M, et al. Risk of tumorigenicity in mesenchymal stromal cell\u2013based therapies\u2014bridging scientific observations and regulatory viewpoints. Cytotherapy. 2013;15:753\u201359.","journal-title":"Cytotherapy"},{"key":"7346_CR277","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41551-018-0325-8","volume":"3","author":"JQ Yin","year":"2019","unstructured":"Yin JQ, Zhu J, Ankrum JA. Manufacturing of primed mesenchymal stromal cells for therapy. Nat Biomed Eng. 2019;3:90\u2013104.","journal-title":"Nat Biomed Eng"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07346-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07346-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07346-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T17:03:55Z","timestamp":1764176635000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07346-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":277,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7346"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07346-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1360"}}